DIPHENHYDRAMINE HYDROCHLORIDE

DIPHENHYDRAMINE HYDROCHLORIDE was reported 166662 times

DIPHENHYDRAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PRESSURE DIASTOLIC ABNORMAL 1766 0.6936
1 VAGINAL FLATULENCE 201 0.6634
2 BLOOD PRESSURE SYSTOLIC ABNORMAL 1572 0.6354
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 247 0.3698
4 NEUROLOGIC NEGLECT SYNDROME 174 0.3129
5 LUPUS VULGARIS 373 0.2960
6 URINE LEUKOCYTE ESTERASE POSITIVE 173 0.2471
7 INFUSION SITE URTICARIA 164 0.2448
8 RETINITIS 399 0.2308
9 TEMPERATURE REGULATION DISORDER 495 0.2220
10 PHARYNGEAL PARAESTHESIA 342 0.2154
11 INFUSION SITE DISCHARGE 374 0.2131
12 INFUSION SITE PRURITUS 650 0.2058
13 CAROTID ARTERY THROMBOSIS 173 0.2038
14 BLOOD PRESSURE DIASTOLIC DECREASED 1452 0.1965
15 INFUSION SITE MASS 210 0.1932
16 INFUSION SITE BRUISING 397 0.1836
17 INFUSION SITE RASH 250 0.1821
18 GRANULOMATOSIS WITH POLYANGIITIS 213 0.1765
19 EAR PRURITUS 613 0.1746
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 352 0.1697
21 BLOOD PRESSURE SYSTOLIC INCREASED 3287 0.1684
22 DEEP VEIN THROMBOSIS POSTOPERATIVE 328 0.1638
23 DISLOCATION OF VERTEBRA 370 0.1621
24 BLOOD PRESSURE DIASTOLIC INCREASED 717 0.1552
25 INFUSION SITE DISCOMFORT 160 0.1543
26 SERONEGATIVE ARTHRITIS 175 0.1527
27 BLOOD PRESSURE FLUCTUATION 3668 0.1527
28 INFUSION RELATED REACTION 10054 0.1515
29 INFUSION SITE SWELLING 909 0.1443
30 PORPHYRIA ACUTE 207 0.1443
31 RED BLOOD CELLS URINE POSITIVE 135 0.1396
32 ADJUSTMENT DISORDER 178 0.1369
33 FEMALE GENITAL TRACT FISTULA 233 0.1363
34 ANTICHOLINERGIC SYNDROME 217 0.1361
35 INFUSION SITE HAEMORRHAGE 445 0.1351
36 X-RAY ABNORMAL 241 0.1346
37 ENTHESOPATHY 205 0.1310
38 WHITE BLOOD CELLS URINE POSITIVE 244 0.1296
39 SOFT TISSUE DISORDER 141 0.1271
40 CHRONIC SPONTANEOUS URTICARIA 142 0.1224
41 CHRONIC SINUSITIS 455 0.1211
42 INFUSION SITE EXTRAVASATION 734 0.1178
43 FOOD ALLERGY 894 0.1157
44 SWOLLEN JOINT COUNT INCREASED 368 0.1153
45 BONE EROSION 406 0.1147
46 POOR VENOUS ACCESS 1180 0.1139
47 INFUSION SITE ERYTHEMA 947 0.1122
48 DEATH NEONATAL 155 0.1114
49 RHEUMATIC FEVER 471 0.1056
50 INFUSION SITE PAIN 1340 0.1039
51 INCORRECT DRUG ADMINISTRATION RATE 440 0.1033
52 BODY TEMPERATURE DECREASED 1011 0.1026
53 BLOOD PARATHYROID HORMONE DECREASED 148 0.0998
54 RADICULOPATHY 260 0.0986
55 TENOSYNOVITIS 260 0.0942
56 C-REACTIVE PROTEIN ABNORMAL 587 0.0914
57 ORAL PRURITUS 206 0.0896
58 MULTIPLE ALLERGIES 698 0.0890
59 RHEUMATOID FACTOR POSITIVE 510 0.0882
60 BODY TEMPERATURE FLUCTUATION 182 0.0873
61 FACET JOINT SYNDROME 272 0.0835
62 DRUG TOLERANCE DECREASED 234 0.0832
63 VEIN RUPTURE 139 0.0830
64 HYPERPARATHYROIDISM SECONDARY 207 0.0825
65 PROCTITIS 231 0.0824
66 LOWER RESPIRATORY TRACT CONGESTION 139 0.0817
67 HEART RATE DECREASED 2806 0.0798
68 NEPHROGENIC ANAEMIA 367 0.0791
69 RHEUMATOID NODULE 216 0.0783
70 RESPIRATORY RATE INCREASED 695 0.0782
71 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 559 0.0779
72 SEASONAL ALLERGY 1099 0.0776
73 URINE ABNORMALITY 351 0.0771
74 MACULAR DEGENERATION 921 0.0770
75 RED BLOOD CELL SEDIMENTATION RATE INCREASED 839 0.0757
76 BURSITIS 915 0.0753
77 RED CELL DISTRIBUTION WIDTH INCREASED 312 0.0750
78 PERSONALITY DISORDER 196 0.0748
79 DUODENAL ULCER PERFORATION 556 0.0747
80 INFUSION SITE REACTION 222 0.0742
81 DEVICE INFUSION ISSUE 181 0.0729
82 OXYGEN SATURATION DECREASED 4072 0.0724
83 PNEUMONIA VIRAL 220 0.0689
84 PERIPHERAL VENOUS DISEASE 278 0.0680
85 PANNICULITIS 163 0.0673
86 ALANINE AMINOTRANSFERASE ABNORMAL 141 0.0668
87 BLOOD PRESSURE SYSTOLIC DECREASED 304 0.0668
88 BACTERIAL TEST POSITIVE 149 0.0668
89 HELICOBACTER INFECTION 685 0.0666
90 EAR INFECTION 1773 0.0666
91 HYPERCHOLESTEROLAEMIA 638 0.0660
92 PEMPHIGUS 811 0.0648
93 SUSPECTED OFF LABEL USE 292 0.0646
94 WOUND INFECTION 700 0.0639
95 THROAT IRRITATION 2865 0.0638
96 BLOOD IMMUNOGLOBULIN G DECREASED 157 0.0633
97 MONOCYTE COUNT INCREASED 229 0.0630
98 FOETAL DEATH 321 0.0618
99 SINUSITIS 6287 0.0613
100 IMMUNODEFICIENCY 912 0.0611
101 HEREDITARY ANGIOEDEMA 648 0.0603
102 INSURANCE ISSUE 921 0.0602
103 WALKING AID USER 393 0.0595
104 UPPER RESPIRATORY TRACT INFECTION 2746 0.0594
105 WEIGHT FLUCTUATION 615 0.0587
106 HAND DEFORMITY 764 0.0582
107 OXYGEN SATURATION ABNORMAL 161 0.0567
108 AUTOIMMUNE DISORDER 552 0.0566
109 SYNOVITIS 1018 0.0564
110 INTENTIONAL PRODUCT USE ISSUE 4943 0.0564
111 DRUG LEVEL BELOW THERAPEUTIC 311 0.0563
112 SINUS CONGESTION 756 0.0559
113 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 355 0.0546
114 EXOSTOSIS 495 0.0542
115 APLASTIC ANAEMIA 283 0.0541
116 MUSCLE INJURY 444 0.0535
117 SERUM SICKNESS 149 0.0534
118 JOINT DISLOCATION 564 0.0533
119 PHARYNGEAL SWELLING 518 0.0529
120 GRIP STRENGTH DECREASED 465 0.0528
121 REBOUND ACID HYPERSECRETION 158 0.0522
122 THROAT TIGHTNESS 1381 0.0510
123 COELIAC DISEASE 499 0.0508
124 PARAESTHESIA ORAL 732 0.0507
125 SUSPECTED SUICIDE 237 0.0505
126 FOOT DEFORMITY 558 0.0503
127 SKIN ABRASION 237 0.0501
128 BODY TEMPERATURE INCREASED 1010 0.0495
129 COMPLETED SUICIDE 4125 0.0495
130 FOLLICULITIS 519 0.0494
131 HALLUCINATIONS, MIXED 208 0.0494
132 PROTEIN URINE PRESENT 246 0.0493
133 JOINT RANGE OF MOTION DECREASED 661 0.0492
134 TONGUE DISORDER 354 0.0489
135 LUPUS-LIKE SYNDROME 438 0.0482
136 URINE ANALYSIS ABNORMAL 144 0.0481
137 DRUG SPECIFIC ANTIBODY PRESENT 308 0.0473
138 BLOOD PRESSURE INCREASED 7222 0.0472
139 DERMATITIS CONTACT 538 0.0471
140 FIBROMYALGIA 1140 0.0468
141 APHTHOUS ULCER 360 0.0464
142 SKIN LACERATION 504 0.0463
143 TOOTH INFECTION 611 0.0463
144 MENINGITIS ASEPTIC 208 0.0463
145 BLOOD CREATININE DECREASED 145 0.0463
146 SUSPECTED COVID-19 152 0.0460
147 JAUNDICE CHOLESTATIC 158 0.0447
148 SKIN INFECTION 500 0.0445
149 URTICARIA 7461 0.0445
150 PERICARDITIS 743 0.0442
151 HYPOMANIA 161 0.0437
152 SINUS DISORDER 867 0.0437
153 SPONDYLITIS 159 0.0437
154 ANAL FISSURE 234 0.0436
155 RESPIRATORY TRACT INFECTION 1127 0.0432
156 LYMPHOCYTE COUNT DECREASED 759 0.0429
157 RHINITIS ALLERGIC 191 0.0429
158 HEART RATE ABNORMAL 235 0.0421
159 PHARYNGITIS STREPTOCOCCAL 453 0.0418
160 BREAST CANCER STAGE III 266 0.0410
161 SENSORY LOSS 330 0.0410
162 HEART RATE IRREGULAR 924 0.0409
163 BRONCHITIS 3026 0.0408
164 HEART RATE INCREASED 4044 0.0408
165 SCIATICA 649 0.0407
166 TENDERNESS 419 0.0402
167 MATERNAL EXPOSURE TIMING UNSPECIFIED 151 0.0402
168 GASTROENTERITIS VIRAL 723 0.0400
169 GANGRENE 241 0.0400
170 PHARYNGITIS 496 0.0399
171 PRESCRIBED OVERDOSE 769 0.0397
172 ORAL CANDIDIASIS 523 0.0397
173 CYSTITIS 1261 0.0396
174 END STAGE RENAL DISEASE 718 0.0393
175 DEMYELINATION 161 0.0392
176 EYE INFECTION 442 0.0391
177 OBSTRUCTION 156 0.0390
178 RHEUMATOID ARTHRITIS 4414 0.0388
179 RESPIRATORY TRACT CONGESTION 615 0.0387
180 STREPTOCOCCAL INFECTION 213 0.0382
181 WOUND 1069 0.0382
182 ARTERIAL OCCLUSIVE DISEASE 300 0.0381
183 ANAPHYLACTIC REACTION 2106 0.0381
184 TOOTH ABSCESS 388 0.0381
185 FLUSHING 3850 0.0378
186 PARANASAL SINUS DISCOMFORT 143 0.0377
187 C-REACTIVE PROTEIN INCREASED 1374 0.0377
188 DRUG LEVEL ABOVE THERAPEUTIC 172 0.0375
189 ARTHROPOD BITE 278 0.0375
190 BRONCHIECTASIS 251 0.0372
191 POST-TRAUMATIC STRESS DISORDER 249 0.0371
192 PULMONARY FIBROSIS 702 0.0366
193 LIP DRY 332 0.0365
194 VASCULITIS 424 0.0364
195 ULCER 579 0.0364
196 VEIN DISORDER 182 0.0363
197 JOINT STIFFNESS 948 0.0361
198 COVID-19 PNEUMONIA 422 0.0357
199 CONTRAINDICATED PRODUCT ADMINISTERED 1082 0.0357
200 IRRITABLE BOWEL SYNDROME 766 0.0357
201 NASOPHARYNGITIS 6571 0.0356
202 EAR PAIN 687 0.0353
203 ORAL INFECTION 138 0.0353
204 RESPIRATORY ARREST 973 0.0353
205 CHEST DISCOMFORT 3598 0.0351
206 SKIN NECROSIS 182 0.0350
207 NEUTROPHIL COUNT INCREASED 357 0.0348
208 VASCULAR DEVICE INFECTION 158 0.0348
209 BLOOD MAGNESIUM DECREASED 297 0.0344
210 RALES 199 0.0342
211 KIDNEY INFECTION 670 0.0341
212 RHINITIS 275 0.0341
213 HALLUCINATION, VISUAL 719 0.0340
214 PRODUCTIVE COUGH 1619 0.0339
215 TOXICITY TO VARIOUS AGENTS 5697 0.0338
216 GLOSSODYNIA 755 0.0337
217 CHILLS 3944 0.0336
218 TEMPERATURE INTOLERANCE 346 0.0335
219 OROPHARYNGEAL PAIN 3089 0.0333
220 DRUG ABUSE 2772 0.0333
221 SNEEZING 745 0.0332
222 DRUG TOXICITY 452 0.0331
223 RASH ERYTHEMATOUS 1585 0.0331
224 CYTOKINE RELEASE SYNDROME 660 0.0329
225 CARDIO-RESPIRATORY ARREST 1374 0.0328
226 HORDEOLUM 142 0.0328
227 EAR DISORDER 150 0.0327
228 BREATH SOUNDS ABNORMAL 161 0.0326
229 HAEMATOCRIT DECREASED 644 0.0324
230 FEELING HOT 1989 0.0324
231 NASAL CONGESTION 1905 0.0324
232 LOCALISED INFECTION 781 0.0323
233 FINGER DEFORMITY 156 0.0322
234 LIGAMENT SPRAIN 315 0.0318
235 VIRAL INFECTION 1059 0.0318
236 FEBRILE NEUTROPENIA 2107 0.0317
237 TYPE 2 DIABETES MELLITUS 1066 0.0316
238 IMPAIRED HEALING 1037 0.0316
239 PULSE ABSENT 150 0.0315
240 PRODUCT DISTRIBUTION ISSUE 292 0.0314
241 EAR DISCOMFORT 323 0.0314
242 FOOD POISONING 168 0.0313
243 MUSCLE SPASTICITY 381 0.0310
244 SKIN PLAQUE 261 0.0309
245 HEPATIC ENZYME INCREASED 2108 0.0309
246 JOINT EFFUSION 213 0.0309
247 INTERVERTEBRAL DISC DEGENERATION 284 0.0307
248 DRUG TOLERANCE 155 0.0306
249 COORDINATION ABNORMAL 426 0.0305
250 SARCOIDOSIS 145 0.0305
251 SCRATCH 321 0.0304
252 BLOOD URINE PRESENT 577 0.0304
253 ARTHROPATHY 1685 0.0303
254 OROPHARYNGEAL DISCOMFORT 273 0.0302
255 VAGINAL INFECTION 142 0.0301
256 RHINORRHOEA 1948 0.0301
257 DRY THROAT 305 0.0300
258 INFLUENZA 3333 0.0299
259 UPPER-AIRWAY COUGH SYNDROME 246 0.0298
260 MULTIPLE DRUG OVERDOSE 148 0.0298
261 JOINT SWELLING 3592 0.0297
262 DERMATITIS ACNEIFORM 181 0.0297
263 HYPERSENSITIVITY 5512 0.0297
264 GASTROINTESTINAL INFECTION 266 0.0296
265 BLOOD IRON DECREASED 352 0.0296
266 WHEEZING 1757 0.0296
267 POSTOPERATIVE WOUND INFECTION 200 0.0296
268 CONCUSSION 228 0.0294
269 NASAL POLYPS 145 0.0294
270 OSTEOARTHRITIS 1246 0.0294
271 LOWER RESPIRATORY TRACT INFECTION 1334 0.0293
272 MOUTH SWELLING 169 0.0293
273 NERVE COMPRESSION 270 0.0292
274 FEELING COLD 811 0.0291
275 SARS-COV-2 TEST POSITIVE 381 0.0288
276 ARTHRITIS 2268 0.0288
277 LOWER LIMB FRACTURE 552 0.0287
278 ATELECTASIS 277 0.0286
279 CHRONIC KIDNEY DISEASE 2177 0.0286
280 HERPES ZOSTER 1645 0.0286
281 TACHYCARDIA 2543 0.0286
282 OBESITY 455 0.0285
283 MUSCULOSKELETAL STIFFNESS 2495 0.0285
284 TOOTH DISORDER 632 0.0284
285 VAGINAL DISCHARGE 286 0.0282
286 SYSTEMIC LUPUS ERYTHEMATOSUS 999 0.0281
287 LIP SWELLING 936 0.0281
288 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 144 0.0281
289 DRUG LEVEL DECREASED 285 0.0280
290 HYPERTENSION 5926 0.0279
291 HEPATIC CIRRHOSIS 525 0.0279
292 HEMIPLEGIA 232 0.0279
293 GINGIVITIS 150 0.0278
294 PSYCHOLOGICAL TRAUMA 240 0.0278
295 POST PROCEDURAL INFECTION 226 0.0278
296 ORAL HERPES 542 0.0277
297 SKIN WARM 161 0.0276
298 SINUS TACHYCARDIA 392 0.0276
299 PRURITUS 10578 0.0275
300 SPUTUM DISCOLOURED 261 0.0275
301 DELIRIUM 953 0.0274
302 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4931 0.0273
303 THERAPEUTIC RESPONSE SHORTENED 907 0.0273
304 PHLEBITIS 140 0.0273
305 LIMB INJURY 741 0.0273
306 JOINT INJURY 581 0.0272
307 COUGH 7599 0.0271
308 UNRESPONSIVE TO STIMULI 699 0.0271
309 RESTLESS LEGS SYNDROME 491 0.0270
310 OSTEOPOROSIS 1108 0.0269
311 SINUS HEADACHE 160 0.0269
312 SWELLING 2515 0.0268
313 ADRENAL INSUFFICIENCY 326 0.0268
314 PULMONARY CONGESTION 354 0.0268
315 DENTAL CARIES 297 0.0268
316 COVID-19 4683 0.0267
317 MIGRAINE 2546 0.0266
318 ERYTHEMA 5479 0.0266
319 SENSITIVITY TO WEATHER CHANGE 140 0.0266
320 INFECTION 3847 0.0266
321 SWOLLEN TONGUE 828 0.0265
322 HIP ARTHROPLASTY 406 0.0265
323 NEURALGIA 644 0.0265
324 SPINAL OSTEOARTHRITIS 232 0.0264
325 BLOOD CHOLESTEROL INCREASED 1230 0.0264
326 SENSATION OF FOREIGN BODY 221 0.0262
327 MYDRIASIS 336 0.0262
328 AFFECT LABILITY 252 0.0262
329 MOTOR DYSFUNCTION 266 0.0261
330 SPINAL DISORDER 247 0.0261
331 RASH PRURITIC 1410 0.0260
332 BLOOD PRESSURE DECREASED 1728 0.0260
333 POISONING 326 0.0259
334 FEAR OF INJECTION 185 0.0259
335 WEIGHT INCREASED 5805 0.0259
336 FREQUENT BOWEL MOVEMENTS 699 0.0258
337 HAIR DISORDER 213 0.0258
338 FLANK PAIN 242 0.0258
339 CLOSTRIDIUM DIFFICILE INFECTION 561 0.0257
340 SLEEP APNOEA SYNDROME 490 0.0256
341 RESPIRATORY DISORDER 768 0.0256
342 DISCOMFORT 1566 0.0256
343 ANAL FISTULA 136 0.0255
344 TOOTH FRACTURE 280 0.0254
345 RED BLOOD CELL COUNT DECREASED 726 0.0254
346 URINARY TRACT INFECTION 4330 0.0254
347 BLOOD PRESSURE ABNORMAL 503 0.0253
348 HYPOAESTHESIA ORAL 380 0.0252
349 NODULE 329 0.0252
350 FISTULA 283 0.0251
351 EATING DISORDER 535 0.0251
352 SKIN HAEMORRHAGE 372 0.0251
353 CELLULITIS 1263 0.0250
354 WHITE BLOOD CELL COUNT INCREASED 961 0.0250
355 VITAMIN D DEFICIENCY 244 0.0250
356 LIVER INJURY 610 0.0248
357 FUNGAL INFECTION 827 0.0248
358 FOOT FRACTURE 470 0.0248
359 MUSCULOSKELETAL CHEST PAIN 383 0.0247
360 HYPOXIA 871 0.0247
361 PRE-EXISTING CONDITION IMPROVED 154 0.0246
362 BLISTER 1385 0.0246
363 CONTUSION 2374 0.0246
364 CARDIAC MURMUR 213 0.0246
365 PERIPHERAL SWELLING 3778 0.0245
366 WEIGHT DECREASED 6830 0.0244
367 RESPIRATORY DEPRESSION 299 0.0244
368 PYREXIA 8438 0.0244
369 PHARYNGEAL OEDEMA 375 0.0244
370 RESPIRATORY SYNCYTIAL VIRUS INFECTION 212 0.0243
371 INJECTION SITE EXTRAVASATION 300 0.0243
372 INFLAMMATION 1251 0.0242
373 TOOTHACHE 437 0.0241
374 BACTERAEMIA 286 0.0241
375 FACIAL PAIN 215 0.0241
376 ASTHMA 2720 0.0240
377 SENSITIVE SKIN 177 0.0240
378 HEMIPARESIS 404 0.0238
379 THERAPEUTIC PRODUCT EFFECT DECREASED 1065 0.0238
380 TACHYPNOEA 323 0.0237
381 PALLOR 646 0.0237
382 MOUTH ULCERATION 499 0.0237
383 ROAD TRAFFIC ACCIDENT 987 0.0236
384 BLOOD URIC ACID INCREASED 136 0.0235
385 SWELLING FACE 1531 0.0235
386 CANDIDA INFECTION 395 0.0234
387 NIGHT SWEATS 753 0.0233
388 SKIN ULCER 604 0.0233
389 PNEUMONIA 7550 0.0233
390 DIVERTICULITIS 646 0.0233
391 BASAL CELL CARCINOMA 363 0.0232
392 ILLNESS 2388 0.0232
393 HYPOTENSION 4640 0.0231
394 MUSCLE STRAIN 199 0.0230
395 EYE SWELLING 855 0.0230
396 STOMATITIS 1392 0.0229
397 HAIR COLOUR CHANGES 285 0.0229
398 SMALL INTESTINAL OBSTRUCTION 281 0.0228
399 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 188 0.0228
400 BACK PAIN 5268 0.0227
401 POOR QUALITY SLEEP 487 0.0226
402 LUNG DISORDER 1105 0.0225
403 ABSCESS 359 0.0225
404 APHONIA 314 0.0225
405 PULMONARY MASS 335 0.0225
406 FLUID RETENTION 1141 0.0224
407 RENAL CYST 178 0.0224
408 MUSCULOSKELETAL PAIN 1174 0.0224
409 MASS 313 0.0224
410 SYMPTOM RECURRENCE 134 0.0224
411 PSEUDOMONAS INFECTION 192 0.0224
412 HYPOAESTHESIA 3335 0.0223
413 RIB FRACTURE 458 0.0222
414 CATARACT 1324 0.0222
415 ORAL PAIN 497 0.0222
416 MENTAL STATUS CHANGES 616 0.0222
417 ARTHRALGIA 9218 0.0221
418 HEADACHE 13883 0.0221
419 KNEE ARTHROPLASTY 466 0.0221
420 HYPERCALCAEMIA 273 0.0221
421 HAIR TEXTURE ABNORMAL 294 0.0220
422 NECK PAIN 1222 0.0218
423 DYSPHAGIA 2073 0.0218
424 OEDEMA 1182 0.0218
425 ANGIOEDEMA 964 0.0218
426 CYST 270 0.0217
427 INFLUENZA LIKE ILLNESS 1788 0.0217
428 TENDONITIS 336 0.0217
429 ILL-DEFINED DISORDER 1314 0.0216
430 MUSCULOSKELETAL DISCOMFORT 372 0.0216
431 MUSCULAR WEAKNESS 2452 0.0216
432 DRUG INTOLERANCE 2082 0.0215
433 SOMNOLENCE 4285 0.0213
434 RASH 9272 0.0212
435 RENAL TUBULAR NECROSIS 208 0.0212
436 INCREASED TENDENCY TO BRUISE 195 0.0212
437 GASTROOESOPHAGEAL REFLUX DISEASE 1703 0.0211
438 THERMAL BURN 150 0.0211
439 CARPAL TUNNEL SYNDROME 296 0.0211
440 HYPERHIDROSIS 2722 0.0211
441 BACTERIAL INFECTION 394 0.0211
442 CHEST PAIN 3904 0.0211
443 WRIST FRACTURE 252 0.0210
444 EOSINOPHIL COUNT INCREASED 175 0.0210
445 COLITIS 793 0.0209
446 MOBILITY DECREASED 1502 0.0209
447 PAPULE 147 0.0208
448 HYPOPHOSPHATAEMIA 154 0.0208
449 CEREBRAL DISORDER 154 0.0208
450 OFF LABEL USE 18216 0.0208
451 RESPIRATORY DISTRESS 574 0.0208
452 RETCHING 443 0.0208
453 MYASTHENIA GRAVIS 167 0.0207
454 CONGENITAL ANOMALY 160 0.0206
455 MENINGITIS 138 0.0206
456 COLD SWEAT 364 0.0206
457 FATIGUE 16065 0.0206
458 CARDIAC ARREST 1700 0.0206
459 BRAIN OEDEMA 260 0.0206
460 CARDIOMEGALY 253 0.0205
461 RASH MACULAR 719 0.0205
462 MADAROSIS 238 0.0205
463 MUSCLE TIGHTNESS 332 0.0205
464 CONJUNCTIVITIS 380 0.0205
465 BLOOD ALBUMIN DECREASED 162 0.0204
466 PERIPHERAL COLDNESS 279 0.0203
467 CLOSTRIDIUM DIFFICILE COLITIS 215 0.0203
468 BLOOD POTASSIUM DECREASED 609 0.0202
469 PULMONARY OEDEMA 906 0.0202
470 GINGIVAL PAIN 161 0.0202
471 HAND FRACTURE 143 0.0202
472 DYSPNOEA EXERTIONAL 758 0.0201
473 NEPHROLITHIASIS 923 0.0201
474 SCAB 228 0.0200
475 UVEITIS 271 0.0200
476 BRAIN FOG 312 0.0199
477 RECTAL HAEMORRHAGE 854 0.0199
478 PSORIATIC ARTHROPATHY 806 0.0198
479 STAPHYLOCOCCAL INFECTION 655 0.0198
480 BLADDER DISORDER 197 0.0198
481 PETECHIAE 207 0.0198
482 DEVICE RELATED INFECTION 305 0.0198
483 LYMPHADENOPATHY 701 0.0198
484 DYSARTHRIA 745 0.0198
485 PRODUCT USE ISSUE 3712 0.0197
486 IRON DEFICIENCY ANAEMIA 182 0.0197
487 INTENTIONAL DRUG MISUSE 412 0.0197
488 HERNIA 381 0.0197
489 VITAMIN D DECREASED 168 0.0196
490 CYANOSIS 309 0.0196
491 GASTROINTESTINAL DISORDER 1757 0.0196
492 PNEUMONIA BACTERIAL 180 0.0196
493 HYPERAESTHESIA 161 0.0196
494 GASTROENTERITIS 286 0.0196
495 SCAR 335 0.0195
496 DYSPEPSIA 1915 0.0194
497 RENAL PAIN 206 0.0194
498 PRESCRIBED UNDERDOSE 387 0.0194
499 IMMUNOSUPPRESSION 171 0.0194
500 DYSPNOEA 10971 0.0194
501 LYMPHOEDEMA 134 0.0194
502 THERAPY NON-RESPONDER 871 0.0194
503 LUNG INFILTRATION 171 0.0193
504 PSYCHOTIC DISORDER 571 0.0193
505 DRY MOUTH 1565 0.0193
506 PROCEDURAL PAIN 534 0.0192
507 PAIN 11797 0.0192
508 ANXIETY 5436 0.0191
509 INCONTINENCE 201 0.0190
510 FRUSTRATION TOLERANCE DECREASED 153 0.0189
511 PRURITUS GENERALISED 409 0.0189
512 SKIN LESION 518 0.0189
513 CHOLELITHIASIS 618 0.0188
514 HAEMOGLOBIN DECREASED 1933 0.0188
515 HYPOALBUMINAEMIA 146 0.0188
516 NEPHROPATHY 175 0.0187
517 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 899 0.0187
518 MUSCLE TWITCHING 431 0.0187
519 HEAD DISCOMFORT 331 0.0187
520 LIMB DISCOMFORT 578 0.0187
521 BRONCHOSPASM 266 0.0186
522 OEDEMA PERIPHERAL 2267 0.0186
523 GALLBLADDER DISORDER 331 0.0185
524 PALPITATIONS 2170 0.0185
525 BURNING SENSATION 1299 0.0185
526 PAIN IN EXTREMITY 5457 0.0185
527 ESCHERICHIA INFECTION 152 0.0185
528 EXPOSURE DURING PREGNANCY 1144 0.0184
529 ABDOMINAL PAIN 4271 0.0183
530 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 957 0.0183
531 BLOOD BILIRUBIN INCREASED 494 0.0183
532 ANAPHYLACTIC SHOCK 471 0.0182
533 INTERVERTEBRAL DISC PROTRUSION 399 0.0182
534 NEUTROPHIL COUNT DECREASED 743 0.0182
535 IMPAIRED QUALITY OF LIFE 262 0.0182
536 SECRETION DISCHARGE 228 0.0182
537 NAUSEA 14399 0.0182
538 FURUNCLE 144 0.0182
539 PARAESTHESIA 2858 0.0181
540 PULMONARY THROMBOSIS 198 0.0181
541 MIDDLE INSOMNIA 338 0.0181
542 OSTEOMYELITIS 327 0.0180
543 SLEEP DISORDER 1272 0.0180
544 COLITIS ULCERATIVE 804 0.0180
545 CONDITION AGGRAVATED 5468 0.0180
546 DECUBITUS ULCER 146 0.0179
547 GOUT 321 0.0179
548 TORSADE DE POINTES 140 0.0178
549 INJURY 1252 0.0178
550 BLOOD TEST ABNORMAL 250 0.0178
551 HIATUS HERNIA 230 0.0177
552 ABDOMINAL DISCOMFORT 2977 0.0177
553 BACK INJURY 193 0.0177
554 HAEMORRHOIDS 346 0.0177
555 WHITE BLOOD CELL COUNT DECREASED 1916 0.0177
556 LACRIMATION INCREASED 532 0.0176
557 HYPERSOMNIA 504 0.0176
558 PLATELET COUNT INCREASED 229 0.0175
559 DYSPHONIA 1021 0.0174
560 ROTATOR CUFF SYNDROME 224 0.0174
561 INTENTIONAL OVERDOSE 1114 0.0173
562 SKIN DISCOLOURATION 798 0.0173
563 MALAISE 7611 0.0173
564 BLOOD CALCIUM DECREASED 195 0.0173
565 HAEMATOCHEZIA 957 0.0173
566 RENAL INJURY 515 0.0173
567 BLOOD UREA INCREASED 290 0.0173
568 PHOTOSENSITIVITY REACTION 286 0.0173
569 FACE OEDEMA 292 0.0173
570 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 294 0.0173
571 OVARIAN CYST 173 0.0173
572 TREATMENT FAILURE 1433 0.0173
573 VENTRICULAR TACHYCARDIA 285 0.0172
574 APHASIA 521 0.0172
575 IMPAIRED GASTRIC EMPTYING 235 0.0172
576 LIVE BIRTH 144 0.0172
577 INSOMNIA 4582 0.0172
578 EYE PRURITUS 578 0.0172
579 EMPHYSEMA 173 0.0171
580 OPTIC NEURITIS 155 0.0170
581 DEHYDRATION 2270 0.0170
582 VOMITING 7997 0.0170
583 ARTERIOSCLEROSIS 160 0.0170
584 ASPIRATION 186 0.0170
585 HEAD INJURY 537 0.0170
586 ANGINA PECTORIS 486 0.0169
587 PHOTOPHOBIA 319 0.0169
588 ALANINE AMINOTRANSFERASE INCREASED 1041 0.0169
589 RASH GENERALISED 438 0.0169
590 UROSEPSIS 156 0.0169
591 ORTHOSTATIC HYPOTENSION 294 0.0169
592 HYPOMAGNESAEMIA 235 0.0169
593 GAIT INABILITY 564 0.0169
594 SUBSTANCE ABUSE 137 0.0168
595 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1197 0.0168
596 TUMOUR LYSIS SYNDROME 148 0.0168
597 DECREASED IMMUNE RESPONSIVENESS 165 0.0168
598 LUNG INFECTION 261 0.0168
599 HOT FLUSH 1266 0.0168
600 IMMUNE SYSTEM DISORDER 221 0.0168
601 LIVER FUNCTION TEST INCREASED 360 0.0168
602 PAIN IN JAW 475 0.0168
603 LETHARGY 960 0.0167
604 TREMOR 2769 0.0167
605 ANAL INCONTINENCE 150 0.0167
606 ANKLE FRACTURE 258 0.0167
607 EYE INFLAMMATION 159 0.0166
608 SKIN FISSURES 324 0.0166
609 MUCOSAL INFLAMMATION 432 0.0165
610 SKIN REACTION 232 0.0165
611 SKIN DISORDER 548 0.0164
612 AGITATION 1205 0.0164
613 PYELONEPHRITIS 142 0.0164
614 INITIAL INSOMNIA 168 0.0164
615 HYPERLIPIDAEMIA 195 0.0163
616 FACIAL PARALYSIS 139 0.0163
617 ASTHENIA 6122 0.0163
618 UPPER LIMB FRACTURE 323 0.0162
619 ASPARTATE AMINOTRANSFERASE INCREASED 859 0.0162
620 HEPATOTOXICITY 359 0.0161
621 URINARY INCONTINENCE 477 0.0161
622 EPISTAXIS 1203 0.0161
623 DRY EYE 800 0.0160
624 HEPATIC STEATOSIS 298 0.0160
625 FALL 5324 0.0160
626 BLOOD ALKALINE PHOSPHATASE INCREASED 397 0.0160
627 MUSCULOSKELETAL DISORDER 304 0.0160
628 CONSTIPATION 3482 0.0159
629 MICTURITION URGENCY 182 0.0159
630 ACUTE RESPIRATORY FAILURE 305 0.0158
631 NEUROPATHY PERIPHERAL 1508 0.0158
632 GASTRIC DISORDER 542 0.0158
633 TRANSFUSION 165 0.0157
634 PNEUMOTHORAX 249 0.0157
635 VENTRICULAR EXTRASYSTOLES 163 0.0157
636 HEPATOMEGALY 154 0.0157
637 ACUTE RESPIRATORY DISTRESS SYNDROME 277 0.0156
638 ACCIDENT 187 0.0156
639 BALANCE DISORDER 1353 0.0156
640 FEELING JITTERY 298 0.0156
641 SPINAL PAIN 183 0.0156
642 OSTEOPENIA 237 0.0156
643 LOSS OF CONSCIOUSNESS 2000 0.0156
644 DYSURIA 574 0.0156
645 SEPSIS 1738 0.0156
646 ELECTROCARDIOGRAM QT PROLONGED 558 0.0155
647 BONE PAIN 908 0.0155
648 EYE DISCHARGE 161 0.0155
649 RESTLESSNESS 567 0.0155
650 MUSCLE SPASMS 2839 0.0155
651 POST PROCEDURAL COMPLICATION 297 0.0155
652 AMNESIA 1006 0.0154
653 SUPRAVENTRICULAR TACHYCARDIA 148 0.0154
654 SKIN SWELLING 134 0.0154
655 DIZZINESS 7696 0.0154
656 BLOOD THYROID STIMULATING HORMONE INCREASED 141 0.0153
657 BACK DISORDER 249 0.0153
658 SCHIZOPHRENIA 186 0.0153
659 ABDOMINAL DISTENSION 1596 0.0153
660 LYMPHOPENIA 216 0.0153
661 GASTRITIS 401 0.0152
662 BLOOD SODIUM DECREASED 287 0.0152
663 URINARY RETENTION 507 0.0152
664 RENAL FAILURE 2016 0.0152
665 DECREASED APPETITE 3523 0.0152
666 THERAPEUTIC RESPONSE DECREASED 917 0.0151
667 PLEURAL EFFUSION 920 0.0151
668 PRESYNCOPE 367 0.0151
669 RASH PAPULAR 338 0.0151
670 BRADYCARDIA 797 0.0150
671 DISABILITY 295 0.0149
672 INTENTIONAL PRODUCT MISUSE 1302 0.0149
673 DRUG ERUPTION 263 0.0148
674 LEUKOCYTOSIS 268 0.0148
675 FEELING ABNORMAL 3542 0.0148
676 HAEMOPTYSIS 412 0.0148
677 NERVOUSNESS 768 0.0147
678 EYE DISORDER 483 0.0147
679 LABORATORY TEST ABNORMAL 433 0.0147
680 GAIT DISTURBANCE 2802 0.0146
681 ACCIDENTAL OVERDOSE 535 0.0146
682 ABDOMINAL PAIN UPPER 3008 0.0146
683 OVERDOSE 3146 0.0146
684 ECZEMA 763 0.0146
685 PLATELET COUNT DECREASED 1543 0.0145
686 ALOPECIA 2839 0.0144
687 ECONOMIC PROBLEM 219 0.0144
688 GENERALISED OEDEMA 178 0.0144
689 PANIC ATTACK 524 0.0144
690 GASTROINTESTINAL PAIN 158 0.0143
691 OCULAR DISCOMFORT 161 0.0143
692 TOOTH EXTRACTION 178 0.0143
693 MALNUTRITION 160 0.0143
694 SPLENOMEGALY 167 0.0142
695 INTENTIONAL DOSE OMISSION 406 0.0142
696 DIPLOPIA 369 0.0142
697 THYROID DISORDER 219 0.0142
698 PRODUCT USE IN UNAPPROVED INDICATION 3509 0.0141
699 SEIZURE 1632 0.0141
700 PRODUCT DOSE OMISSION ISSUE 4148 0.0141
701 CONFUSIONAL STATE 2277 0.0141
702 BLOOD CREATININE INCREASED 916 0.0140
703 SEROTONIN SYNDROME 269 0.0140
704 HYPOKALAEMIA 644 0.0139
705 DIZZINESS POSTURAL 135 0.0139
706 PNEUMONITIS 379 0.0139
707 SPEECH DISORDER 729 0.0139
708 COGNITIVE DISORDER 648 0.0139
709 FEEDING DISORDER 281 0.0138
710 PARALYSIS 198 0.0138
711 BODY HEIGHT DECREASED 147 0.0137
712 PSYCHOMOTOR HYPERACTIVITY 228 0.0137
713 DIARRHOEA 8866 0.0137
714 VERTIGO 833 0.0137
715 TINNITUS 627 0.0136
716 QUALITY OF LIFE DECREASED 183 0.0136
717 NERVE INJURY 151 0.0136
718 PROTEINURIA 258 0.0136
719 HYPOKINESIA 197 0.0136
720 BONE DISORDER 247 0.0135
721 CHOKING 264 0.0135
722 SLUGGISHNESS 138 0.0135
723 ATRIAL FIBRILLATION 1316 0.0135
724 LEUKOPENIA 675 0.0135
725 NEOPLASM 155 0.0135
726 TASTE DISORDER 273 0.0134
727 DEPRESSION 3051 0.0134
728 MITRAL VALVE INCOMPETENCE 151 0.0133
729 GENERAL PHYSICAL HEALTH DETERIORATION 1543 0.0133
730 SKIN CANCER 287 0.0133
731 DERMATITIS 279 0.0133
732 ANAEMIA 2539 0.0133
733 BRAIN INJURY 133 0.0133
734 HYPOTHYROIDISM 423 0.0132
735 ILEUS 164 0.0132
736 BIPOLAR DISORDER 143 0.0131
737 ACUTE KIDNEY INJURY 2008 0.0131
738 EYE PAIN 739 0.0131
739 PREGNANCY 262 0.0131
740 SYNCOPE 1305 0.0130
741 MYALGIA 2217 0.0130
742 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 223 0.0130
743 OCULAR HYPERAEMIA 617 0.0130
744 POLLAKIURIA 540 0.0129
745 THROMBOCYTOPENIA 1448 0.0129
746 ABDOMINAL PAIN LOWER 327 0.0129
747 LIVER FUNCTION TEST ABNORMAL 376 0.0129
748 PNEUMONIA ASPIRATION 323 0.0129
749 OESOPHAGITIS 141 0.0129
750 FEAR 347 0.0129
751 MATERNAL EXPOSURE DURING PREGNANCY 1149 0.0129
752 OBSTRUCTIVE AIRWAYS DISORDER 143 0.0128
753 MULTIPLE SCLEROSIS 614 0.0128
754 HALLUCINATION, AUDITORY 204 0.0128
755 ELECTROLYTE IMBALANCE 149 0.0128
756 ANHEDONIA 337 0.0128
757 MUSCLE RIGIDITY 153 0.0128
758 DEVICE OCCLUSION 180 0.0128
759 PRODUCT PRESCRIBING ERROR 301 0.0126
760 INJECTION SITE URTICARIA 310 0.0126
761 PERICARDIAL EFFUSION 292 0.0126
762 METABOLIC ACIDOSIS 403 0.0126
763 GINGIVAL BLEEDING 172 0.0126
764 MOVEMENT DISORDER 404 0.0126
765 DRUG LEVEL INCREASED 208 0.0126
766 HIP FRACTURE 403 0.0125
767 THROMBOSIS 1004 0.0125
768 PANCREATITIS 657 0.0124
769 MYOCARDIAL ISCHAEMIA 141 0.0124
770 MEMORY IMPAIRMENT 1700 0.0124
771 DIABETES MELLITUS 942 0.0123
772 INJECTION SITE PRURITUS 827 0.0123
773 PRODUCT AVAILABILITY ISSUE 281 0.0123
774 DEPRESSED LEVEL OF CONSCIOUSNESS 488 0.0123
775 DISORIENTATION 488 0.0123
776 ORAL DISCOMFORT 171 0.0123
777 HYPERGLYCAEMIA 446 0.0122
778 THERAPEUTIC RESPONSE UNEXPECTED 549 0.0122
779 FULL BLOOD COUNT DECREASED 244 0.0121
780 GLAUCOMA 233 0.0121
781 COMA 576 0.0121
782 SENSORY DISTURBANCE 193 0.0120
783 ENCEPHALOPATHY 295 0.0120
784 MYOCLONUS 143 0.0120
785 SPINAL FRACTURE 240 0.0120
786 SHOCK 275 0.0119
787 LIVER DISORDER 529 0.0119
788 BLOOD LACTATE DEHYDROGENASE INCREASED 189 0.0119
789 THERAPY PARTIAL RESPONDER 186 0.0119
790 CRYING 433 0.0119
791 THINKING ABNORMAL 221 0.0118
792 MULTI-ORGAN FAILURE 205 0.0118
793 SEDATION 310 0.0118
794 DEEP VEIN THROMBOSIS 764 0.0117
795 DIABETES MELLITUS INADEQUATE CONTROL 208 0.0117
796 SKIN EXFOLIATION 990 0.0117
797 RESPIRATORY FAILURE 849 0.0116
798 TUBULOINTERSTITIAL NEPHRITIS 218 0.0116
799 DYSKINESIA 469 0.0115
800 CARDIOMYOPATHY 169 0.0114
801 VISUAL IMPAIRMENT 1410 0.0114
802 SPINAL OPERATION 140 0.0114
803 UNEVALUABLE EVENT 858 0.0113
804 BLOOD POTASSIUM INCREASED 184 0.0113
805 THIRST 202 0.0113
806 INCREASED APPETITE 216 0.0113
807 VISION BLURRED 1544 0.0112
808 COMPLICATION ASSOCIATED WITH DEVICE 163 0.0112
809 FLATULENCE 633 0.0112
810 GASTRIC ULCER 212 0.0111
811 ADVERSE REACTION 147 0.0111
812 PRODUCT ADMINISTRATION ERROR 224 0.0111
813 GLOMERULAR FILTRATION RATE DECREASED 136 0.0111
814 HALLUCINATION 834 0.0111
815 SUICIDE ATTEMPT 669 0.0110
816 DYSTONIA 214 0.0110
817 DYSSTASIA 322 0.0110
818 PARANOIA 190 0.0110
819 PULMONARY EMBOLISM 1046 0.0110
820 INTESTINAL OBSTRUCTION 414 0.0110
821 HYPOPHAGIA 279 0.0109
822 GENERALISED TONIC-CLONIC SEIZURE 180 0.0109
823 ASCITES 315 0.0107
824 COAGULOPATHY 178 0.0107
825 FLUID OVERLOAD 155 0.0106
826 MANIA 175 0.0106
827 CARDIAC DISORDER 992 0.0106
828 INJECTION SITE SWELLING 810 0.0106
829 PANCYTOPENIA 590 0.0105
830 TRANSIENT ISCHAEMIC ATTACK 356 0.0105
831 CHROMATURIA 238 0.0105
832 MEDICATION ERROR 586 0.0105
833 SEPTIC SHOCK 457 0.0105
834 CARDIOGENIC SHOCK 150 0.0104
835 RENAL DISORDER 486 0.0104
836 DEPRESSED MOOD 549 0.0104
837 MENTAL DISORDER 451 0.0104
838 HUNGER 144 0.0103
839 CENTRAL NERVOUS SYSTEM LESION 142 0.0103
840 INTERNATIONAL NORMALISED RATIO INCREASED 294 0.0103
841 AKATHISIA 140 0.0102
842 EMOTIONAL DISORDER 316 0.0102
843 RASH MACULO-PAPULAR 228 0.0102
844 BLOOD TRIGLYCERIDES INCREASED 181 0.0102
845 INJECTION SITE RASH 314 0.0102
846 ARRHYTHMIA 483 0.0102
847 LOCAL SWELLING 177 0.0101
848 LYMPHOMA 155 0.0100
849 ADVERSE DRUG REACTION 899 0.0100
850 UNDERDOSE 730 0.0100
851 DRY SKIN 1330 0.0100
852 HAEMATURIA 340 0.0099
853 HAEMATOMA 257 0.0099
854 NEUTROPENIA 1346 0.0099
855 DISSEMINATED INTRAVASCULAR COAGULATION 139 0.0099
856 DRUG-INDUCED LIVER INJURY 309 0.0098
857 DISTURBANCE IN ATTENTION 531 0.0098
858 PULMONARY HYPERTENSION 205 0.0098
859 PSORIASIS 1268 0.0097
860 INTERSTITIAL LUNG DISEASE 470 0.0097
861 CONVULSION 555 0.0097
862 MULTIPLE SCLEROSIS RELAPSE 665 0.0097
863 PRODUCT DOSE OMISSION IN ERROR 274 0.0097
864 DISEASE PROGRESSION 1140 0.0096
865 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 526 0.0096
866 ACUTE MYOCARDIAL INFARCTION 280 0.0095
867 PAIN OF SKIN 255 0.0095
868 HYPONATRAEMIA 533 0.0095
869 EJECTION FRACTION DECREASED 146 0.0094
870 DYSGEUSIA 696 0.0094
871 BLOOD COUNT ABNORMAL 142 0.0094
872 DEAFNESS 243 0.0093
873 IRRITABILITY 558 0.0093
874 IMPAIRED WORK ABILITY 198 0.0093
875 INJECTION SITE WARMTH 190 0.0092
876 FAECES DISCOLOURED 199 0.0092
877 DELUSION 142 0.0091
878 ACNE 688 0.0091
879 INJECTION SITE REACTION 624 0.0091
880 NEEDLE ISSUE 262 0.0090
881 HAEMORRHAGE 932 0.0089
882 HYPOCALCAEMIA 168 0.0089
883 CARDIAC FAILURE CONGESTIVE 710 0.0088
884 FEMUR FRACTURE 273 0.0088
885 RENAL FAILURE ACUTE 372 0.0088
886 BLOOD CREATINE PHOSPHOKINASE INCREASED 252 0.0087
887 DRUG INEFFECTIVE 11534 0.0087
888 INCORRECT PRODUCT ADMINISTRATION DURATION 189 0.0087
889 INJECTION SITE ERYTHEMA 1082 0.0087
890 MENTAL IMPAIRMENT 209 0.0086
891 BLINDNESS 350 0.0086
892 HAEMATEMESIS 216 0.0085
893 RENAL IMPAIRMENT 713 0.0085
894 SUICIDAL IDEATION 771 0.0084
895 TRANSAMINASES INCREASED 187 0.0084
896 HYPOGLYCAEMIA 404 0.0083
897 PELVIC PAIN 151 0.0083
898 BLOOD GLUCOSE DECREASED 399 0.0083
899 DRUG INTERACTION 1305 0.0082
900 CORONARY ARTERY DISEASE 249 0.0082
901 ADVERSE EVENT 752 0.0082
902 DEMENTIA 228 0.0082
903 MOOD SWINGS 257 0.0081
904 NERVOUS SYSTEM DISORDER 250 0.0080
905 ACTIVITIES OF DAILY LIVING IMPAIRED 158 0.0080
906 CEREBROVASCULAR ACCIDENT 1344 0.0079
907 NEUROTOXICITY 139 0.0079
908 MOOD ALTERED 216 0.0079
909 NEOPLASM MALIGNANT 527 0.0079
910 DISEASE RECURRENCE 375 0.0079
911 HYPERKALAEMIA 275 0.0078
912 HEPATIC FAILURE 236 0.0078
913 STEVENS-JOHNSON SYNDROME 174 0.0078
914 NIGHTMARE 269 0.0078
915 EYE IRRITATION 445 0.0077
916 INCORRECT DOSE ADMINISTERED 1761 0.0077
917 ERUCTATION 149 0.0077
918 BONE MARROW FAILURE 156 0.0077
919 ANGER 259 0.0077
920 HYPOACUSIS 329 0.0076
921 ABNORMAL BEHAVIOUR 300 0.0076
922 AGGRESSION 377 0.0075
923 TREATMENT NONCOMPLIANCE 412 0.0075
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 166 0.0075
925 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 172 0.0074
926 AGEUSIA 184 0.0074
927 BLOOD GLUCOSE ABNORMAL 136 0.0074
928 PLASMA CELL MYELOMA 286 0.0073
929 EXTRAPYRAMIDAL DISORDER 182 0.0073
930 DERMATITIS ATOPIC 385 0.0073
931 TOOTH LOSS 151 0.0073
932 EMOTIONAL DISTRESS 875 0.0072
933 MULTIPLE ORGAN DYSFUNCTION SYNDROME 200 0.0071
934 SKIN IRRITATION 323 0.0070
935 RHABDOMYOLYSIS 294 0.0070
936 GASTROINTESTINAL HAEMORRHAGE 588 0.0070
937 DEATH 6056 0.0070
938 LUNG NEOPLASM MALIGNANT 288 0.0070
939 HEPATITIS 179 0.0070
940 SURGERY 409 0.0070
941 BLOOD GLUCOSE INCREASED 1287 0.0068
942 PRODUCT PRESCRIBING ISSUE 148 0.0068
943 SKIN BURNING SENSATION 482 0.0067
944 INJECTION SITE MASS 247 0.0067
945 THERAPY INTERRUPTED 470 0.0066
946 GLYCOSYLATED HAEMOGLOBIN INCREASED 164 0.0065
947 ABASIA 159 0.0064
948 BONE DENSITY DECREASED 197 0.0063
949 TARDIVE DYSKINESIA 177 0.0063
950 JAUNDICE 164 0.0061
951 HOSPITALISATION 928 0.0060
952 MYOCARDIAL INFARCTION 1053 0.0060
953 INJECTION SITE BRUISING 479 0.0060
954 NEOPLASM PROGRESSION 203 0.0058
955 EXPIRED PRODUCT ADMINISTERED 194 0.0058
956 ABNORMAL DREAMS 160 0.0058
957 CEREBRAL HAEMORRHAGE 205 0.0057
958 CARDIAC FAILURE 459 0.0057
959 DRUG EFFECT DECREASED 306 0.0057
960 WITHDRAWAL SYNDROME 238 0.0057
961 DIABETIC KETOACIDOSIS 133 0.0055
962 INJECTION SITE PAIN 1697 0.0055
963 MALIGNANT NEOPLASM PROGRESSION 566 0.0055
964 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 180 0.0053
965 DRUG ADMINISTRATION ERROR 157 0.0051
966 VAGINAL HAEMORRHAGE 222 0.0051
967 PRODUCT DOSE OMISSION 328 0.0050
968 OSTEONECROSIS 164 0.0050
969 FOETAL EXPOSURE DURING PREGNANCY 402 0.0049
970 DRUG EFFECT INCOMPLETE 178 0.0049
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 335 0.0047
972 LACTIC ACIDOSIS 152 0.0047
973 EPILEPSY 140 0.0046
974 PRODUCT QUALITY ISSUE 622 0.0046
975 THERAPY CESSATION 235 0.0046
976 HEPATIC FUNCTION ABNORMAL 168 0.0045
977 ABORTION SPONTANEOUS 178 0.0044
978 EXTRA DOSE ADMINISTERED 176 0.0043
979 VISUAL ACUITY REDUCED 144 0.0043
980 NO ADVERSE EVENT 754 0.0042
981 DEVICE ISSUE 361 0.0040
982 INJECTION SITE HAEMORRHAGE 320 0.0040
983 DRUG DOSE OMISSION 661 0.0040
984 MYELOSUPPRESSION 139 0.0039
985 WRONG TECHNIQUE IN DRUG USAGE PROCESS 139 0.0038
986 BREAST CANCER 348 0.0037
987 DEVICE DISLOCATION 161 0.0037
988 DRUG WITHDRAWAL SYNDROME 322 0.0037
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 736 0.0036
990 PRODUCT SUBSTITUTION ISSUE 206 0.0036
991 DRUG DEPENDENCE 569 0.0035
992 DEVICE MALFUNCTION 182 0.0026
993 ACCIDENTAL EXPOSURE TO PRODUCT 247 0.0024
994 PROSTATE CANCER 142 0.0018